SCHEMBL25735722

SCHEMBL25735722

Cc1ccn(-c2ccc(C)c(Cl)c2)n1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 6/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
ATM Q13315 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
OXTR P30559 2/20 0.44
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
AVPR1A P37288 2/20 0.41
PKM P14618 2/20 0.41
SIGMAR1 Q99720 1/20 0.39
STAT1 P42224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2615992 0.87 NOTUM (0.51) AVPR2HTTRAB9ANPC1ATM
SCHEMBL15984869 0.83 HTT (0.50) HTTRAB9ANPC1ATMMEN1
SCHEMBL13662723 0.83 NPC1 (0.50) HTTRAB9ANPC1ATMMEN1
SCHEMBL16911272 0.83 RAB9A (0.54) AVPR2HTTRAB9ANPC1ATM
SCHEMBL16201986 0.83 KCNH2 (0.46) AVPR2HTTRAB9ANPC1ATM
SCHEMBL17720573 0.83 HTT (0.44) AVPR2HTTRAB9ANPC1ATM
SCHEMBL12967879 0.83 NPC1 (0.43) AVPR2HTTRAB9ANPC1ATM
SCHEMBL17885744 0.80 NPC1 (0.41) HTTRAB9ANPC1ATMMEN1
SCHEMBL16911898 0.80 RAB9A (0.50) AVPR2HTTRAB9ANPC1MEN1
SCHEMBL16202096 0.79 KCNH2 (0.46) AVPR2HTTRAB9ANPC1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES THE BROAD INSTITUTE, INC. 2024-01-25 US disclosed
US-20230192904-A1 BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF THE BROAD INSTITUTE, INC. 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240024490-A1 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES COASY, JMJD7, PTMS AVPR2 4834/4885HTT 3723/4885RAB9A 2367/4885
US-20230192904-A1 BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF ERBB2, ACP1, TK1 AVPR2 4864/4885HTT 4428/4885RAB9A 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.